Barry Canton net worth
Quick answer
Barry Canton's estimated net worth is $18.75M (range $13.12M – $28.12M) as of 2026. Barry Canton is Founder at Ginkgo Bioworks. Ginkgo Bioworks valuation.
Barry Canton is Founder at Ginkgo Bioworks (YC S14). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Public
- Background: Irish
- Education: PhD in Biological Engineering from MIT; MEngSc in Mechanical Engineering from University College Dublin; BEng in Mechanical Engineering from University College Dublin.
- Region: United States of America
- Industries: Healthcare, Industrial Bio
- Team size: 641
- Website: http://ginkgobioworks.com
Who is Barry Canton?
Barry Canton is a co-founder and Chief Technology Officer of Ginkgo Bioworks, where he is responsible for the overall foundry technology strategy and direction.
Highlights:
- University College Dublin
- Massachusetts Institute of Technology (MIT)
- Co-founded Ginkgo Bioworks
Background
He was born and raised in Ireland and moved to the US to study at MIT in 2003 at the age of 23. Heritage/background labels may be inferred and are not verified identity documents.
About Ginkgo Bioworks
Ginkgo Bioworks is the organism company. We design custom organisms for customers across multiple markets. We build our foundries to scale the process of organism engineering using software and hardware automation. Organism engineers at Ginkgo learn from nature to develop new organisms that replace technology with biology.
FAQ: Barry Canton net worth and Ginkgo Bioworks valuation
What is Barry Canton's net worth?
Barry Canton's estimated net worth is $18.75M (range $13.12M – $28.12M) as of 2026. Barry Canton is Founder at Ginkgo Bioworks. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Ginkgo Bioworks valuation?
Ginkgo Bioworks's estimated valuation on Entrepreneurial Check is $2.0B. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Barry Canton's role?
Barry Canton is Founder at Ginkgo Bioworks, a Y Combinator-backed startup (batch S14).